Treatment with compound 1 during the incubation significantly inhibited overexpression of HoxA11 and HoxA13 (Fig. 7d), showing degradation of mENL could downregulate aberrant gene expression in Wilms tumor. The gene discussed is HOXA13; the disease is Wilms tumor.